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of pro-angiogenic factors by SC. In IL-1beta treated SC, CS increased the
mRNA expression of the anti-angiogenic factors TSP-1 and VEGI (p < 0.01).
TSP-2 was not affected by CS. The mRNA of anti-angiogenic factors Ang-2
and PF-4 were not detected in our culture conditions.
Conclusions: Synovium inﬂammation is associated with an imbalance
between pro- and anti-angiogenic factors production. IL-1beta is a key
inﬂammatory mediator capable of inducing this pro-angiogenic imbalance.
CS trends to normalize the IL-1beta-induced angiogenic response in OA SC.
This could constitute a new mechanism of action of this drug, modulating
the molecular mechanisms underlying the synovium angiogenesis in OA.
These results also contribute to understand the molecular mechanism of
angiogenesis in OA, leading, in the future, to the development of new
promising therapeutic agents.
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Purpose: The exact mechanism for cartilage degeneration in osteoarthritis
(OA) is not yet fully known. Although chondrocytes are considered to be
most responsible, synovium could also play a certain role in the loss of car-
tilage. If synovium is indeed involved in cartilage degeneration, a catabolic
factor(s) released from synovium may be found within the synovial ﬂuid. In
this study, we attempted to ﬁnd a possible catabolic factor(s) for cartilage
matrix in synovial ﬂuid from knee OA patients.
Methods: Synovial ﬂuid analysis. The institutional review boards approved
the study project. Synovial ﬂuid was collected from OA knees in the
early stages of the disease (K/L grade I-III) (Early OA knees; n = 53),
and those in the late stage (K/L grade IV) (Advanced OA knees; n = 32).
Concentrations of type II collagen neo-epitope (CIINE) and aggrecan core
protein (ACP), keratin sulfate (KS), and sulfated glucosaminoglycan (sGAG)
were determined respectively to estimate the rate of matrix degeneration.
To ﬁnd possible catabolic factors for cartilage matrix, concentrations of 57
factors that could induce matrix degradation, such as MMPs, cytokines and
chemokines, were determined in those samples by Luminex and ELISA.
Correlation of concentration was investigated between those factors and
the above four cartilage degenerative products.
Determination of the source of possible catabolic factors. Synovial tissues
were obtained from 18 Advanced OA knees with medial involvement for
gene expression analysis by qPCR. Control synovium and cartilage were
obtained from 8 disease-free knees of age-matched donors. In those knees,
synovium was harvetsted at medial, lateral, and patellofemoral compart-
ment, respectively. Synovial tissues from another 8 OA knees were used
to obtain synovial cells. The cells were isolated by enzymic digestion, and
were separated into CD14+ and CD14- cells by magnetic sorting, and gene
expression was analyzed respectively. Some synovial tissues were used for
immunohistochemistry.
Measurement of collagenolytic activity of OA synovial ﬂuid. Synovial ﬂuid
samples from 8 Early OA knees were incubated respectively with bovine
type II collagen with or without MMP activation by APMA. After incubation
at 37°C for 48 hours, the increase in CIINE concentration was determined
by ELISA.
Results: Among the 57 factors evaluated, the concentrations of MMP-1
and 3 were signiﬁcantly correlated with those of the cartilage degenerative
products in both sample groups (Table 1).
The synovial ﬂuid from OA knees contained considerable amounts of
MMP-1 and MMP-3, and their concentrations were closely correlated.
Consistently, the expression of MMP-1 and MMP-3 was highly enhanced
in OA synovium compared with the control, and their expression levels
were strongly correlated there. Although the tissues were obtained from
medially involved knees, these MMPs were expressed at similar levels
across the three compartments. The expression of those MMPs was more
enhanced in CD14- synoviocytes than in CD14+ cells, which was consistent
with the result of immunohistochemistry.
In the last experiment, the concentration of CIINE increased little when the
synovial ﬂuid was incubated with bovine type II collagen. However, when
the MMPs in the ﬂuid were activated by APMA, the CIINE concentration in-
creased dramatically by the incubation in all 8 samples. This collagenolysis
could be ascribed to MMP-1, as the synovial ﬂuid contained little MMP-8
or 13.
Type II collagen degenerative product:
Table 1A. Correlation between CIINE and MMPs




Table 1B. Correlation between ACP and MMPs
Early OA Advanced OA
MMP-1 p<0.001 NS
MMP-3 p<0.01 p<0.05
Conclusions: In OA joints, ﬁbroblast-like synoviocytes may release MMP-1
and MMP-3 into synovial ﬂuid, which could play a certain role in cartilage
degeneration. MMPs (most likely MMP-1) in synovial ﬂuid can degrade
type II collagen rather eﬃciently when activated, even in the presence of
TIMPs and α2-macroglobulin in the ﬂuid.
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Purpose: Inﬂammation hypothesis of aging suggests that molecular in-
ﬂammation could be an underpinning of aging and age-related diseases,
as Rheumatoid Arthritis (RA). Besides, mitochondrial alterations may
contribute to the progression of RA. In this study, we investigated the re-
lationship between mitochondrial dysfunction and the in vitro expression
of cyclooxigenase-2 (COX-2), prostaglandin E2 (PGE2), and interleukin-8
(IL-8) in normal human synoviocytes.
Method: Commonly used inhibitors to induce mitochondrial dysfunction
were employed [Antimycin A (AA) and Oligomycin (OLI), inhibitors of
complexes III and V of mitochondrial respiratory chain (MRC), respectively]
in synoviocytes. IL-1β and TNF-α were used as inﬂammatory mediators. To
identify possible pathways, we used N-acetylcysteine as ROS scavenger; the
natural antioxidant resveratrol; and BAY as an inhibitor of NF-kB activation.
COX-2 protein and mRNA expression and both PGE2 and IL-8 levels were
analyzed by ﬂow cytometry, RT-PCR and ELISA, respectively.
Results: First, we found that exposure of synoviocytes to AA and OLI signif-
icantly increased COX-2 protein expression in a time- and dose-dependent
manner. The maximal response was observed at 6h with 20μg/ml AA and
25μg/ml OLI (3.0±0.3, n=4, p<0.001 and 6.5±1.9, n=9 p<0.001, respec-
tively vs. basal 1) while the positive control, 1ng/ml IL-1β, expression
was 12.6±3.4. Quantiﬁcation of COX-2 mRNA expression at 4h showed
similar results. PGE2 levels were also signiﬁcantly increased when cells
were stimulated for 9h with OLI. Second, we tested if mitochondrial
dysfunction could modulate the response induced by sub-optimal doses
of IL-1β (0.1ng/ml) on COX-2 protein expression and PGE2 production.
We found that pre-treatment of synoviocytes with 10μg/ml OLI for 30
minutes signiﬁcantly increases the IL-1β-induced COX-2 protein expression
(32.5±2.5 OLI+IL-1β vs. 6.5±2.4 IL-1β and 4.5±1.7 OLI, n=3, p<0.001) and
COX-2 mRNA expression. Similar results were obtained when PGE2 produc-
tion was assessed (277.0±67.6 OLI+IL-1β vs. 15.4±2.6 IL-1β and 97.5±45.6
OLI, expressed as pg/50,000cells, n=3 duplicate, p<0.005). Equivalent re-
sults were observed when TNF-α or AA was employed. Besides, we also
explored that OLI together with IL-1β signiﬁcantly potentiates the expres-
sion of the pro-inﬂammatory chemokine IL-8 (2886.6±272.6 OLI+IL-1β vs.
1313.1±201.2 IL-1β and 62.4±15.4 OLI, expressed as pg/50,000cells, n=4,
p<0.001).
Finally, we observed that this inﬂammatory response was counteracted
by the addition of N-acetylcysteine, resveratrol or BAY, demonstrating the
involvement of ROS and NF-kB in this process.
